Abstract
Movements of transmembrane segments (TMs) 3 and 6 play a key role in activation of G protein-coupled receptors. However, the underlying molecular processes that govern these movements, and accordingly control receptor activation, remain unclear. To elucidate the importance of the conserved aspartic acid (Asp-130) in the Asp-Arg-Tyr motif of the β2 adrenergic receptor (β2AR), we mutated this residue to asparagine (D130N) to mimic its protonated state, and to alanine (D130A) to fully remove the functionality of the side chain. Both mutants displayed evidence of constitutive receptor activation. In COS-7 cells expressing either D130N or D130A, basal levels of cAMP accumulation were clearly elevated compared with cells expressing the wild-type β2AR. Incubation of COS-7 cell membranes or purified receptor at 37°C revealed also a marked structural instability of both mutant receptors, suggesting that stabilizing intramolecular constraints had been disrupted. Moreover, we obtained evidence for a conformational rearrangement by mutation of Asp-130. In D130N, a cysteine in TM 6, Cys-285, which is not accessible in the wild-type β2AR, became accessible to methanethiosulfonate ethylammonium, a charged, sulfhydryl-reactive reagent. This is consistent with a counterclockwise rotation or tilting of TM 6 and provides for the first time structural evidence linking charge-neutralizing mutations of the aspartic acid in the DRY motif to the overall conformational state of the receptor. We propose that protonation of the aspartic acid leads to release of constraining intramolecular interactions, resulting in movements of TM 6 and, thus, conversion of the receptor to the active state.
Footnotes
- Received January 27, 1999.
- Accepted April 20, 1999.
-
Send reprint requests to: Dr. Ulrik Gether, Division of Cellular and Molecular Physiology, Department of Medical Physiology 12–5-22, The Panum Institute, University of Copenhagen, DK-2200 Copenhagen N, Denmark. E-mail: gether{at}mfi.ku.dk
-
The study was supported in part by the Danish Natural Science Research Council, the Danish Cancer Society, the Danish Heart Foundation, and the NOVO Nordisk Foundation. U.G. is the recipient of an Ole Rømer Associate Research Professorship from the Danish Natural Science Research Council. In addition, this work was supported in part by National Institues of Health Grants MH57324 and MH54137, by the G. Harold & Leila Y. Mathers Charitable Trust, and by the Lebovitz Trust (J.A.J.).
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|